A Nomogram with the Keloid Activity Assessment Scale for Predicting the Recurrence of Chest Keloid after Surgery and Radiotherapy

Springer Science and Business Media LLC - Tập 47 - Trang 872-879 - 2022
Yan Hao1, Zhengyun Liang1, Hao Liu2, Mengjie Shan1, Yijun Xia1, Kexin Song2, Youbin Wang2
1Peking Union Medical College, Chinese Academy of Medical Sciences, Peking Union Medical College Hospital, Beijing, China
2Department of Plastic Surgery, Peking Union Medical College Hospital, Xicheng District, Beijing, China

Tóm tắt

Patients with chest keloids undergoing surgery and adjuvant radiotherapy still have a high recurrence rate, which is a critical problem. The level of keloid activity has not been studied, and a nomogram model for predicting keloid recurrence has not been established in previous studies. A total of 145 patients with chest keloids who underwent surgery and radiotherapy between January 2015 and January 2019 at Peking Union Medical College Hospital were included in our study. Demographic and clinical features and the score of KAAS were analyzed. We compared the area under the curve (AUC) and decision curve analysis (DCA) between KAAS and the Vancouver scar scale (VSS) and established a nomogram model for predicting the risk of recurrence. We used bootstrap and calibration plots to evaluate the performance of the nomogram. The KAAS can predict recurrence in patients with chest keloids after surgery and radiotherapy. Areas under the curve (AUCs) of KAAS and VSS were 0.858 and 0.711, respectively (p < 0.001). Decision curve analysis (DCA) demonstrated that the KAAS was better than the VSS. Complications after treatment may be risk factors for keloid recurrence. We created a nomogram by using complications and KAAS. The AUC was 0.871 (95% CI 0.812–0.930). The ROC of the model’s bootstrap was 0.865 and was well calibrated. The KAAS can be used to predict the recurrence and we developed a nomogram for predicting the recurrence of chest keloids after surgery and adjuvant radiotherapy. This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .

Tài liệu tham khảo

Ekstein SF, Wyles SP, Moran SL, Meves A (2021) Keloids: a review of therapeutic management. Int J Dermatol 60(6):661–671. https://doi.org/10.1111/ijd.15159 Lee SS, Yosipovitch G, Chan YH, Goh CL (2004) Pruritus, pain, and small nerve fiber function in keloids: a controlled study. J Am Acad Dermatol 51(6):1002–1006. https://doi.org/10.1016/j.jaad.2004.07.054 Ogawa R, Tosa M, Dohi T, Akaishi S, Kuribayashi S (2019) Surgical excision and postoperative radiotherapy for keloids. Scars Burn Heal 5:2059513119891113. https://doi.org/10.1177/2059513119891113 Miles OJ, Zhou J, Paleri S, Fua T, Ramakrishnan A (2021) Chest keloids: effect of surgical excision and adjuvant radiotherapy on recurrence, a systematic review and meta-analysis. ANZ J Surg 91(6):1104–1109. https://doi.org/10.1111/ans.16561 Ogawa R, Mitsuhashi K, Hyakusoku H, Miyashita T (2003) Postoperative electron-beam irradiation therapy for keloids and hypertrophic scars: retrospective study of 147 cases followed for more than 18 months. Plast Reconstr Surg 111(2):547–53. https://doi.org/10.1097/01.PRS.0000040466.55214.35 (Discussion 54-5) Wagner W, Alfrink M, Micke O, Schafer U, Schuller P, Willich N (2000) Results of prophylactic irradiation in patients with resected keloids—a retrospective analysis. Acta Oncol 39(2):217–220. https://doi.org/10.1080/028418600430806 Maemoto H, Iraha S, Arashiro K, Ishigami K, Ganaha F, Murayama S (2020) Risk factors of recurrence after postoperative electron beam radiation therapy for keloid: comparison of long-term local control rate. Rep Pract Oncol Radiother 25(4):606–611. https://doi.org/10.1016/j.rpor.2020.05.001 Maemoto H, Ishigami K, Iraha S, Arashiro K, Kusada T, Ganaha F et al (2020) Analyses of size and computed tomography densitometry parameters for prediction of keloid recurrence after postoperative electron beam radiation therapy. Skin Res Technol 26(1):125–131. https://doi.org/10.1111/srt.12775 Ogawa R, Akaishi S, Kuribayashi S, Miyashita T (2016) Keloids and hypertrophic scars can now be cured completely: recent progress in our understanding of the pathogenesis of keloids and hypertrophic scars and the most promising current therapeutic strategy. J Nippon Med Sch 83(2):46–53. https://doi.org/10.1272/jnms.83.46 Park SY (2018) Nomogram: an analogue tool to deliver digital knowledge. J Thorac Cardiovasc Surg 155(4):1793. https://doi.org/10.1016/j.jtcvs.2017.12.107 Hoshino N, Hida K, Sakai Y, Osada S, Idani H, Sato T et al (2018) Nomogram for predicting anastomotic leakage after low anterior resection for rectal cancer. Int J Colorectal Dis 33(4):411–418. https://doi.org/10.1007/s00384-018-2970-5 Jeong SH, Kim RB, Park SY, Park J, Jung EJ, Ju YT et al (2020) Nomogram for predicting gastric cancer recurrence using biomarker gene expression. Eur J Surg Oncol 46(1):195–201. https://doi.org/10.1016/j.ejso.2019.09.143 Pan YX, Chen JC, Fang AP, Wang XH, Chen JB, Wang JC et al (2019) A nomogram predicting the recurrence of hepatocellular carcinoma in patients after laparoscopic hepatectomy. Cancer Commun 39(1):55. https://doi.org/10.1186/s40880-019-0404-6 Shen J, Lian X, Sun Y, Wang X, Hu K, Hou X et al (2015) Hypofractionated electron-beam radiation therapy for keloids: c of 568 cases with 834 lesions. J Radiat Res 56(5):811–817. https://doi.org/10.1093/jrr/rrv031 Maeda T, Funayama E, Yamamoto Y, Murao N, Osawa M, Ishikawa K et al (2021) Long-term outcomes and recurrence-free interval after the treatment of keloids with a standardized protocol. J Tissue Viabil 30(1):128–132. https://doi.org/10.1016/j.jtv.2020.11.003 Furtado F, Hochman B, Farber PL, Muller MC, Hayashi LF, Ferreira LM (2012) Psychological stress as a risk factor for postoperative keloid recurrence. J Psychosom Res 72(4):282–287. https://doi.org/10.1016/j.jpsychores.2011.12.010 Park TH, Seo SW, Kim JK, Chang CH (2011) Outcomes of surgical excision with pressure therapy using magnets and identification of risk factors for recurrent keloids. Plast Reconstr Surg 128(2):431–439. https://doi.org/10.1097/PRS.0b013e31821e7006 Huang C, Ogawa R (2014) The link between hypertension and pathological scarring: does hypertension cause or promote keloid and hypertrophic scar pathogenesis? Wound Repair Regen 22(4):462–466. https://doi.org/10.1111/wrr.12197 Ogawa R (2017) Keloid and hypertrophic scars are the result of chronic inflammation in the reticular dermis. Int J Mol Sci. https://doi.org/10.3390/ijms18030606 Venter C, Eyerich S, Sarin T, Klatt KC (2020) Nutrition and the immune system: a complicated tango. Nutrients. https://doi.org/10.3390/nu12030818 Berman B, Maderal A, Raphael B (2017) Keloids and hypertrophic scars: pathophysiology, classification, and treatment. Dermatol Surg 43(Suppl 1):S3–S18. https://doi.org/10.1097/DSS.0000000000000819 Hirata M, Kamatani Y, Nagai A, Kiyohara Y, Ninomiya T, Tamakoshi A et al (2017) Cross-sectional analysis of BioBank Japan clinical data: a large cohort of 200,000 patients with 47 common diseases. J Epidemiol 27(3S):S9–S21. https://doi.org/10.1016/j.je.2016.12.003 Goltsman D, Munabi NCO, Ascherman JA (2017) The association between smoking and plastic surgery outcomes in 40,465 patients: an analysis of the American college of surgeons national surgical quality improvement program data sets. Plast Reconstr Surg 139(2):503–511. https://doi.org/10.1097/PRS.0000000000002958 Martin ET, Kaye KS, Knott C, Nguyen H, Santarossa M, Evans R et al (2016) Diabetes and risk of surgical site infection: a systematic review and meta-analysis. Infect Control Hosp Epidemiol 37(1):88–99. https://doi.org/10.1017/ice.2015.249